医药制造业产业链、创新链融合对策研究——基于长三角和德国比较视角

    Research on Countermeasures for Integration of Pharmaceutical Manufacturing Industry Chain and Innovation Chain: Based on the Comparative Perspective of Yangtze River Delta and Germany

    • 摘要:
      目的 基于德国医药制造业发展的对比研究,探索长三角医药制造业产业链、创新链的融合路径。
      方法 以长三角医药制造业为研究对象,探究其产业链、创新链融合度,并与德国医药制造业双链融合度进行比较研究。
      结果 2012—2021年长三角双链耦合协调度从中度失调上升到良好协调,呈现上升趋势;德国医药制造业双链耦合协调度高于长三角,其中长三角医药制造业产业链优于德国,德国医药制造业创新链优于长三角。
      结论 长三角医药制造业双链融合应加强龙头企业培育,加大基础研发投入,加速创新要素集聚,加强打造各类服务平台。

       

      Abstract:
      OBJECTIVE To explore the integration path of the industrial chain and innovation chain in the Yangtze River Delta based on the comparative study of the pharmaceutical manufacturing industry in Germany.
      METHODS This paper took the Yangtze River Delta pharmaceutical manufacturing industry as the research object, explored the integration degree of its industrial chain and innovation chain, and conducted a comparative study with the dual-chain integration degree of the German pharmaceutical manufacturing industry.
      RESULTS In 2012—2021, the dual-chain coupling and coordination degree of Yangtze River Delta rose from moderate disorder to good coordination, showing an upward trend; the dual-chain coupling and coordination degree of German pharmaceutical manufacturing industry was higher than that of Yangtze River Delta, in which the Yangtze River Delta pharmaceutical manufacturing industry chain was better than that of Germany, and the innovation chain of Germany's pharmaceutical manufacturing industry was better than that of Yangtze River Delta.
      CONCLUSION The pharmaceutical manufacturing industry in the Yangtze River Delta should strengthen the leading enterprises, increase the investment in basic research and development, accelerate the agglomeration of innovation elements, and build various service platforms.

       

    /

    返回文章
    返回